Home > Gastrointestinal Oncology > Liver Cancer
    Content Type:
  • Liver Cancer

    An Introduction to Liver Cancer

    The treatment of hepatic cell carcinoma holds numerous challenges, and there are currently limited treatment options with proven efficacy. Developments in the treatment landscape, including the introduction of several oral tyrosine kinase inhibitors, monoclonal antibodies and immune checkpoint inhibitors targeting PD-1 and PD-L1, have been important additions to improve patient outcomes. New potential treatments currently under investigation include A3 adenosine receptor (A3AR) agonists, fibroblast growth factor receptor 4 (FGFR4) inhibitors and multikinase inhibitors.

    Expert video highlights, insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.

    Our supporting partners do not constitute an endorsement of the content on this page.

    Liver Cancer Content

    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar